What Pharos Capital Partners does

Pharos Capital Partners is a Dallas-based, physician-founded private equity firm established in 1998 by Dr. Kneeland Youngblood, a former ER physician, and Bob Crants. Since 2013 the firm has operated as a dedicated healthcare-only investor, deploying $25 million to $50 million per transaction into established U.S. healthcare companies that serve rural, urban, and tribal underserved communities, with stated impact measured against GIIN IRIS+ healthcare metrics and six UN Sustainable Development Goals. The firm manages $1.5 billion+ in assets across five fund vintages (Pharos Capital Partners I, II, III, III-A, and IV/IV-A) and has invested in 53+ portfolio companies spanning behavioral health, dialysis and renal care, hospice and home health, primary care, medical devices, surgical services, and healthcare staffing, collectively operating 1,600+ care locations across all 50 states.

The firm's core "products" are its portfolio operating companies rather than a single technology platform; selected platforms include FasPsych (telepsychiatry), Sanderling Renal Services and Renal Care 360° (dialysis, tele-nephrology, and ML-assisted chronic kidney disease management), RhythMedix (wearable cardiac ECG monitoring with 4G connectivity), Complete Health (Medicare value-based primary care), Beacon Specialized Living Services and The Family Treatment Network (behavioral health and developmental disability services), THEMA Health Services (hospice, home health, palliative care), Vantage Surgical Solutions (mobile cataract surgery), and Tribal Health (staffing and consulting for Native American communities across 18 states). Pharos's primary technology asset at the firm level is a proprietary impact-measurement methodology verified by independent consultants against all 14 GIIN IRIS+ healthcare metrics; at the portfolio level, Renal Care 360° applies machine learning to identify vulnerable CKD and ESKD patients for early intervention.

Pharos generates revenue through conventional private equity fund economics, earning management fees on committed or invested capital across its fund vintages and carried interest on realized exits (notable realizations include MOTION PT Group in 2023 and TechLab, Inc. in 2022). The firm does not disclose specific fee rates or revenue figures; pricing and fund terms are negotiated bilaterally with limited partners including foundations, family offices, and institutional investors. Distribution is relationship-driven, supported by offices in Dallas, Nashville, Baltimore, and Silicon Valley, a dedicated investor portal, a corporate website, and a LinkedIn presence, with deal sourcing directed toward healthcare founders and operators and partnership engagement with payors, hospitals, health systems, and governmental agencies serving underserved populations.

Name

Pharos Capital Partners

Legal name

Pharos Capital Group, LLC

Website

http://www.pharosfunds.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharos Capital Partners is a Dallas-based, physician-founded private equity firm that invests $25-$50 million per deal in U.S. healthcare companies serving rural, urban, and tribal underserved communities, managing $1.5B+ across five fund vintages and 53+ portfolio companies.

Ownership category

akta.pro rank

Product category

Healthcare Private Equity / Investment Management

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

akta.pro secondary industry

Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure) (FSAAALAG)

Keywords

• Healthcare private equity
• Private equity funds
• Healthcare investment management
• Minority business enterprise
• Fund management services

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others, Technology or R&D

Revenue model

1. Private Equity Fund Management: Pharos generates revenue through management fees and carried interest from their private equity funds (Pharos Capital Partners I, II, III, III-A, and IV). They invest $25-$50 million per deal in healthcare companies serving underserved communities with the goal of achieving competitive, risk-adjusted returns through realized investments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Pharos Capital Group is a physician-founded private equity firm that manages healthcare-focused investment funds (Pharos Capital Partners I, II, III, III-A, and IV), deploying $25 to $50 million of growth equity into established U.S.-based healthcare companies serving rural, urban, and tribal underserved communities. The firm generates returns for limited partners (foundations, family offices, institutional investors) through management fees and carried interest while building a portfolio of healthcare service and medical device companies.

Product overview

Pharos Capital Group is a physician-founded healthcare private equity investment firm, not a product company. The firm operates as a platform of 15+ active portfolio companies across diverse healthcare sectors including telehealth (FasPsych), dialysis/renal services (Sanderling Renal Services, Renal Care 360°), behavioral health (The Family Treatment Network, Beacon Specialized Living, Seaside Healthcare), medical devices (RhythMedix cardiac monitoring), primary care (Complete Health), developmental disability services (Baroco Corporation), surgical services (Vantage Surgical Solutions), and healthcare staffing (Tribal Health, Medfinders). The portfolio includes both current investments and realized exits (TechLab, Aurora Imaging, MOTION PT Group). Each portfolio company operates as an independent healthcare service provider or medical device manufacturer serving underserved rural, urban, and tribal communities across the United States.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharos Capital Partners IV Fund Healthcare-focused private equity fund managed by Pharos Capital Group that deploys growth equity into established U.S.-based healthcare companies serving underserved communities. Available to foundations, family offices, and institutional investors as limited partner subscriptions.
• Pharos Capital Partners IV-A LP (RBIC)

Quantifiable outcome

• Portfolio companies tripled average employee count during Pharos ownership
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Welsh, Carson, Anderson & Stowe: Long-established U.S. private equity firm focused exclusively on healthcare and technology, with a similar growth-equity orientation, mid-market deal sizes, and a portfolio spanning healthcare services and providers. Direct comparability to Pharos in mandate, fund structure, and LP base.
• Health Enterprise Partners: Growth equity firm focused on healthcare services and healthcare IT for middle-market companies. Comparable to Pharos in growth-equity mandate, healthcare-only focus, and partnership-style approach with founder-led businesses.
• Vistria Group: Chicago-based middle-market private equity firm with a strong healthcare, education, and essential-services focus and explicit impact-investing orientation. Closely comparable to Pharos in mission-driven healthcare PE, mid-market deal sizes, and underserved-community focus.
• Linden Capital Partners: Healthcare-dedicated middle-market private equity firm with multiple funds, focused on healthcare services, pharma services, and medical products. Closely comparable to Pharos in fund size, healthcare-only mandate, and middle-market check size.
• New Mountain Capital: Healthcare-focused growth equity firm with multiple billion-dollar funds, investing in middle-market healthcare services, healthcare IT, and pharma services. Comparable in AUM scale, healthcare-only focus, and growth-equity deal sizes similar to Pharos's $25-50M range.
• Avista Capital Partners: Healthcare-focused middle-market private equity firm investing in healthcare services, pharma, and medical devices. Directly comparable to Pharos in sector focus, fund size, and growth-equity orientation toward established healthcare companies.
• Varsity Healthcare Partners: Lower middle-market private equity firm exclusively focused on healthcare services, with control investments in founder-owned businesses. Comparable to Pharos in healthcare-only focus, founder/operator partnership model, and deal-size range.
• Cressey & Company: Healthcare-dedicated middle-market private equity firm based in Chicago, focused on healthcare services and technology. Highly comparable to Pharos in fund size, sector exclusivity, and growth-stage investments.

Broad incumbents

• Bain Capital Double Impact: Impact-focused private equity strategy within Bain Capital targeting measurable social and environmental outcomes alongside financial returns. Comparable to Pharos in impact-investing orientation and GIIN-aligned measurement, though backed by a much larger generalist platform.
• KKR Health Care Strategic Growth: Healthcare-dedicated growth equity strategy within KKR, a global mega-PE platform. Overlaps with Pharos in healthcare services and growth-stage mandate but operates at significantly larger fund size and broader LP base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharos-capital-group

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries11 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A15 records

Investments23 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharos Capital Partners